Results 221 to 230 of about 3,573,509 (380)

Host-Directed Therapies Based on Protease Inhibitors to Control <i>Mycobacterium tuberculosis</i> and HIV Coinfection. [PDF]

Microorganisms
Mandal M, Pires D, Azevedo-Pereira JM, Anes E.   +3 more
europepmc   +1 more source

Purification and Some Characteristics of the Human Epidermal SH-Protease Inhibitor

, 1978
Mikko Järvinen
openalex   +1 more source

The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors [PDF]

, 1986
J Batlle, MF Lopez Fernandez, M Campos, B Justica, C Berges, JL Navarro, JM Diaz Cremades, CK Kasper, JA Dent, ZM Ruggeri   +9 more
openalex   +1 more source

Engineering Topographical Cues to Enhance Neural Regeneration in Spinal Cord Injury: Overcoming Challenges and Advancing Therapies

Advanced Functional Materials, EarlyView.
Spinal cord injury (SCI) poses significant challenges for regeneration due to a series of secondary injury mechanisms. How to use biomaterial approach to target the failed regeneration after SCI remains a critical challenge. This review systematically evaluates current strategies to optimize biomaterial topographies for neurite outgrowth, axonal ...
Wei Xu, Fenghui Wang, Joshua Stein, Siqiao Wang, Pengfei Jiang, Letao Yang, Liming Cheng, Ki‐Bum Lee   +7 more
wiley   +1 more source

Protocol to generate human monocyte-derived macrophages in the absence of exogenous proteases and protease inhibitors to study proteolysis. [PDF]

STAR Protoc
Bernaerts E, Vandooren J.
europepmc   +1 more source

Inhibition of Macromolecular Synthesis in Escherichia coli by Protease Inhibitors

, 1974
Toby G. Rossman, Catherine J. Norris, Walter Troll   +2 more
openalex   +1 more source

Glepaglutide‐Loaded Foam for the Induction of Mucosal Healing in the Treatment of Inflammatory Bowel Disease

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
Glepaglutide (GL), a GLP‐2 analog with an extended half‐life (50 h), is currently undergoing clinical trials for patients with short bowel syndrome. GL requires subcutaneous injection, which poses challenges for potential patient compliance. To address this challenge, we loaded GL into a rectal foam formulation using CO2 as a permeation enhancer to ...
Wunan Zhang, William Van den Bossche, Hafsa Yagoubi, Espoir K Kambale, Khadija Wahni, Tanya Saxena, Léo Guilbaud, Tom G. Moreels, Joris Messens, Ana Beloqui   +9 more
wiley   +1 more source

Amino acid sequence of serine protease inhibitor CI-1 from barley. Homology with barley inhibitor CI-2, potato inhibitor I, and leech eglin [PDF]

, 1982
Ib Svendsen, S. Boisen, Jørn Hejgaard
openalex   +1 more source

The protease inhibitors and HIV-associated bone loss

Current Opinion in HIV and AIDS, 2016
Caitlin A. Moran, Neale Weitzmann, Ighoverha Ofotokun   +2 more
semanticscholar   +1 more source

Glucocorticoids Alter Bone Microvascular Barrier via MAPK/Connexin43 Mechanisms

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
Osteoporosis induced by Glucocorticoids (GCs) is a common complication of long‐term GC use in patients with inflammatory and autoimmune conditions, often leading to an increased fracture risk. A 3D bicellular endo‐osteo microfluidic platform is developed to explore pathogenic mechanisms underlying GCs‐induced osteoporosis, highlighting a novel MAPK ...
Eun‐Jin Lee, Peter Lialios, Micaila Curtis, James Williams IV, Yoontae Kim, Paul Salipante, Steven Hudson, Mandy B. Esch, Moshe Levi, Joanna Kitlinska, Stella Alimperti   +10 more
wiley   +1 more source